Physician profile
James D King
NPI 1144256157
$2,259.35
in general payments reported to CMS, 2019-2025
23 companies · $146 in 2025
The $146 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,465 · 2020: $326 · 2021: $181 · 2022: $127 · 2024: $14.94 · 2025: $146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $161.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $161.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $413.39 | 2019-2025 | Breztri |
| Amgen INC. | $359.00 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $303.20 | 2019-2020 | |
| Novo Nordisk INC | $245.00 | 2019-2025 | Ozempic |
| Pfizer INC. | $137.99 | 2019 | |
| Glaxosmithkline, LLC. | $122.75 | 2019-2025 | Trelegy Ellipta |
| Sunovion Pharmaceuticals INC. | $121.25 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $71.60 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $58.96 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $57.51 | 2019 | |
| Abbvie INC. | $51.44 | 2021-2022 | |
| Astellas Pharma US INC | $49.17 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $46.57 | 2019 | |
| Abbott Laboratories | $43.55 | 2022-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $28.51 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $22.72 | 2019 | |
| Allergan, INC. | $22.55 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $19.28 | 2025 | Rexulti |
| Bioventus LLC | $18.43 | 2019 | |
| Acadia Pharmaceuticals INC | $18.10 | 2025 | Nuplazid |
| Mylan Specialty L.P. | $16.81 | 2020 | |
| Exact Sciences Corporation | $16.12 | 2025 | Cologuard Collection Kit |
| Avanir Pharmaceuticals, INC. | $15.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.